At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company's management is unaware of any material change in the ...

VANCOUVER, BC / ACCESS Newswire / January 24, 2025 / At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company ...

VANCOUVER, BC / ACCESS Newswire / January 29, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its non-brokered private ...

VANCOUVER, BC / ACCESS Newswire / January 24, 2025 / At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company's ...

ON BEHALF OF ONCO-INNOVATIONS LIMITED, "Thomas O'Shaughnessy" Chief Executive Officer For more information, please contact: Thomas O'Shaughnessy Chief Executive Officer Tel: + 1 888 261 8055 ...

Onco-Innovations Limited, a Canadian-based company dedicated to cancer research and treatment, specializing in oncology, has provided information on its licensed technology of a new class of PNKP ...

VANCOUVER, BC / ACCESS Newswire / January 30, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its licensed ...

Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / January 29, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt ...

I confess that like a lot of people, I am guilty of not getting in my steps. After hours at my desk, the thought of changing, driving to the gym and working out is so exhausting that I end up back ...

At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company's management is unaware of any material change in the ...

Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6, 2024 ...